Table 3.
Comparison between the Ttwo Studied Groups According to rs2046211
| Breast cancer (n = 60) n (%) |
Control (n = 40) n (%) |
(χ2) p | OR | 95% CI | |
|---|---|---|---|---|---|
| rs2046211 | |||||
| CC® | 54 (90.0) | 28 (70.0) | 0.011* | ||
| CG | 6 (10.0) | 12 (30.0) | |||
| GG | 0 (0.0) | 0 (0.0) | 0.26 | 0.088 to 0.76 | |
| Allele | |||||
| C® | 114 (95.0) | 68 (85.0) | 0.015* | 0.298 | 0.11 to 0.83 |
| G | 6 (5.0) | 12 (15.0) | |||
®, Reference Genotype; χ2, Chi square test; p, p value for comparing between the studied groups; *, Statistically significant at p ≤ 0.05; OR, odds ratio; CI, confidence interval